Promising Advances in Heart Failure Treatment
Kilder
- Nature: Cardiotropic AAV gene therapy for heart failure: a phase 1 trial - Nature
- Nature: Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trial - Nature
- Nature: CCR5-targeted allogeneic gamma–delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy - Nature
- Fiercebiotech: Panacea potential: How Nobel-winning regulatory T cells could become a ‘universal drug’ - Fierce Biotech
- Biospace: Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss - BioSpace
- Biospace: Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral - BioSpace
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.